Kotak's fund to part-finance Matrix Pharma's acquisition of Viatris's API biz

Kotak Alternate Asset Managers Limited (KAAML) has invested Rs 1,445 crore ($173 million) to part-finance Matrix Pharma’s acquisition of the active pharmaceutical ingredients (API) business of Viatris. The investment has been made through the Strategic Situations Fund II of KAAML, according to a statement.